Sunnyvale, California — Aurora SFC Systems is pleased to announce that it has successfully closed a Series B venture capital financing. The round was led by Aphelion Capital with participation from California Technology Partners, the Arbor Group and several prominent Silicon Valley investors. The new capital will be used to accelerate the company’s growth in all segments of the business with a particular focus on market and product development.

Aurora SFC Systems is the leading provider of high performance analytical SFC instruments for the scientific chromatography market. Founded in 2007 by Dr. Terry Berger, Aurora SFC is now producing and delivering a new generation of SFC instrument modules that set performance standards never before experienced with SFC. This new funding continues the upward trajectory of Aurora SFC that was highlighted by the announcement at Pittcon 2010 of an OEM agreement that allows Agilent Technologies to incorporate Aurora’s SFC Fusion A5 instrument into a new Agilent SFC system.*

“This investment marks a significant milestone for Aurora SFC Systems and is a strong endorsement of our strategy and execution. We are proud of our technology innovations, our partnership with Agilent, and we greatly appreciate the growing acceptance of our analytical SFC products by our loyal customers” said Dr. Berger, Founder and Chief Science Office. “We are pleased to have the support of this stellar investment group, given their strong track record and deep experience in working with emerging growth companies to achieve success.”

“Aurora SFC has all the elements we look for in an excellent investment opportunity – it is capital efficient, has an outstanding technology platform and demonstrated product performance. The impressive customer base and experienced team were a great fit for our investment model.” said Ned Scheetz, Partner with Aphelion Capital. “We are delighted to have the opportunity to work with California Technology Ventures, The Arbor Group and Roy Rogers as we build Aurora into a world-class SFC instrumentation company.” As part of this financing, Ned Scheetz, Dorothy Pavloff and Nick Farwell have joined the Aurora SFC Board of Directors. Aurora is very proud to announce that veteran instrumentation executive, TZ Chu, has also joined its Board of Directors. TZ brings his extensive experience as co-founder and CEO of Finnigan Corp to help guide and direct Aurora’s growth.

About Aurora SFC Systems Inc. Headquartered in Sunnyvale, CA, Aurora SFC Systems is on a mission to demonstrate the wide application and substantial value of SFC as a technique entirely comparable to traditional reversed phase chromatography. Our passion for delivering better separation solutions has resulted in the Aurora SFC Fusion A5– an analytical SFC instrument as powerful as it is elegant in its concept. With R&D and Production facilities in southeastern Pennsylvania and global distribution partners, Aurora SFC is poised to deliver the next generation of SFC instruments to scientist

around the world. www.aurorasfc.com

About Aphelion Capital

Founded in 2005, Aphelion Capital, LLC is a venture capital

supporting the growth of innovative medical technology with an emphasis on fast to

intense products that reduce the cost of delivering quality healthcare. The Aphelion team

experience investing in healthcare companies across both the private and public equity

www.aphelioncapital.net

About California Technology Ventures

Based in Pasadena, CA, California Technology specializes in technology and life science companies. With a broad portfolio of medical, technology companies, and equally diverse partners, CTV is adept at meeting the strategic, and relationship needs of its portfolio companies. www.ctventures.com

About Rogers Investments Mr. Roy Rogers is a private equity investor focused on technology companies. Mr. Rogers has been the general partner of two venture capital limited partnerships,

Ventures I and II. Mr. Rogers spent 15 years at Hambrecht & Quist. Mr. Rogers has been

round investments in a variety of significant Silicon Valley companies, including Intel, Apple

Microsystems.

About Arbor Group

Mr. Nick Farwell is a private equity investor focused primarily on companies, both public and private. From 1980 until its sale in 1999, Mr. Farwell was RCM Global Investors, a San Francisco-based investment counseling firm.

* http://www.agilent.com/about/newsroom/presrel/2010/03mar-ca10017.html